These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 14643955)

  • 1. Neuropsychological outcome after fractionated stereotactic radiotherapy (FSRT) for base of skull meningiomas: a prospective 1-year follow-up.
    Steinvorth S; Welzel G; Fuss M; Debus J; Wildermuth S; Wannenmacher M; Wenz F
    Radiother Oncol; 2003 Nov; 69(2):177-82. PubMed ID: 14643955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective analysis of neuropsychological deficits following resection of benign skull base meningiomas.
    Zweckberger K; Hallek E; Vogt L; Giese H; Schick U; Unterberg AW
    J Neurosurg; 2017 Dec; 127(6):1242-1248. PubMed ID: 28186454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of stereotactic radiosurgery, hypofractionated, and fractionated stereotactic radiotherapy in the treatment of skull base meningioma.
    Han J; Girvigian MR; Chen JC; Miller MJ; Lodin K; Rahimian J; Arellano A; Cahan BL; Kaptein JS
    Am J Clin Oncol; 2014 Jun; 37(3):255-60. PubMed ID: 23241504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skull base meningiomas: Long-term results and patient self-reported outcome in 507 patients treated with fractionated stereotactic radiotherapy (FSRT) or intensity modulated radiotherapy (IMRT).
    Combs SE; Adeberg S; Dittmar JO; Welzel T; Rieken S; Habermehl D; Huber PE; Debus J
    Radiother Oncol; 2013 Feb; 106(2):186-91. PubMed ID: 22906549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractionated stereotactic conformal radiotherapy for large benign skull base meningiomas.
    Minniti G; Clarke E; Cavallo L; Osti MF; Esposito V; Cantore G; Cappabianca P; Enrici RM
    Radiat Oncol; 2011 Apr; 6():36. PubMed ID: 21486436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single dose versus fractionated stereotactic radiotherapy for meningiomas.
    Lo SS; Cho KH; Hall WA; Kossow RJ; Hernandez WL; McCollow KK; Gerbi BJ; Higgins PD; Lee CK; Dusenbery KE
    Can J Neurol Sci; 2002 Aug; 29(3):240-8. PubMed ID: 12195613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome after high-precision radiotherapy for skull base meningiomas: Pooled data from three large German centers for radiation oncology.
    Combs SE; Farzin M; Boehmer J; Oehlke O; Molls M; Debus J; Grosu AL
    Radiother Oncol; 2018 May; 127(2):274-279. PubMed ID: 29598834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early and late effects of local high dose radiotherapy of the brain on memory and attention].
    Duchstein S; Gademann G; Peters B
    Strahlenther Onkol; 2003 Jul; 179(7):441-51. PubMed ID: 12835880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: long-term results.
    Debus J; Wuendrich M; Pirzkall A; Hoess A; Schlegel W; Zuna I; Engenhart-Cabillic R; Wannenmacher M
    J Clin Oncol; 2001 Aug; 19(15):3547-53. PubMed ID: 11481362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meningioma of the skull base: long-term outcome after image-guided stereotactic radiotherapy.
    Kaul D; Budach V; Misch M; Wiener E; Exner S; Badakhshi H
    Cancer Radiother; 2014 Dec; 18(8):730-5. PubMed ID: 25307475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractionated stereotactic radiotherapy in the treatment of exclusive cavernous sinus meningioma: functional outcome, local control, and tolerance.
    Brell M; Villà S; Teixidor P; Lucas A; Ferrán E; Marín S; Acebes JJ
    Surg Neurol; 2006 Jan; 65(1):28-33; discussion 33-4. PubMed ID: 16378847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome after particle therapy for meningiomas of the skull base: toxicity and local control in patients treated with active rasterscanning.
    El Shafie RA; Czech M; Kessel KA; Habermehl D; Weber D; Rieken S; Bougatf N; Jäkel O; Debus J; Combs SE
    Radiat Oncol; 2018 Mar; 13(1):54. PubMed ID: 29587795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy and radiosurgery for benign skull base meningiomas.
    Minniti G; Amichetti M; Enrici RM
    Radiat Oncol; 2009 Oct; 4():42. PubMed ID: 19828022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of fractionated stereotactic radiotherapy for intracranial skull base benign meningiomas in single institution.
    Onodera S; Aoyama H; Katoh N; Taguchi H; Yasuda K; Yoshida D; Surtherland K; Suzuki R; Ishikawa M; Gerard B; Terasaka S; Shirato H
    Jpn J Clin Oncol; 2011 Apr; 41(4):462-8. PubMed ID: 21177777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fractionated stereotactic radiation therapy in the management of benign cavernous sinus meningiomas : long-term experience and review of the literature.
    Milker-Zabel S; Zabel-du Bois A; Huber P; Schlegel W; Debus J
    Strahlenther Onkol; 2006 Nov; 182(11):635-40. PubMed ID: 17072520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. State-of-the-art treatment alternatives for base of skull meningiomas: complementing and controversial indications for neurosurgery, stereotactic and robotic based radiosurgery or modern fractionated radiation techniques.
    Combs SE; Ganswindt U; Foote RL; Kondziolka D; Tonn JC
    Radiat Oncol; 2012 Dec; 7():226. PubMed ID: 23273161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractionated stereotactic radiation therapy improves cranial neuropathies in patients with skull base meningiomas: a retrospective cohort study.
    Shen X; Andrews DW; Sergott RC; Evans JJ; Curran WJ; Machtay M; Fragoso R; Eldredge H; Champ CE; Witek M; Mishra MV; Dicker AP; Werner-Wasik M
    Radiat Oncol; 2012 Dec; 7():225. PubMed ID: 23270432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors.
    Milker-Zabel S; Zabel A; Schulz-Ertner D; Schlegel W; Wannenmacher M; Debus J
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):809-16. PubMed ID: 15708260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypofractionated stereotactic radiation therapy in skull base meningiomas.
    Navarria P; Pessina F; Cozzi L; Clerici E; Villa E; Ascolese AM; De Rose F; Comito T; Franzese C; D'Agostino G; Lobefalo F; Fogliata A; Reggiori G; Fornari M; Tomatis S; Bello L; Scorsetti M
    J Neurooncol; 2015 Sep; 124(2):283-9. PubMed ID: 26040487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photon-based fractionated stereotactic radiotherapy for postoperative treatment of skull base chordomas.
    Bugoci DM; Girvigian MR; Chen JC; Miller MM; Rahimian J
    Am J Clin Oncol; 2013 Aug; 36(4):404-10. PubMed ID: 22772429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.